Ana R. Quesada graduated in chemistry from the University of
Granada (Spain) and obtained her Ph.D. in biochemistry at the University of
Málaga (Spain). She has been a visiting scientist at the University of Bristol
(UK) and at the UWM (Wisconsin, USA). After working for seven years in the research
departments of pharmaceutical companies, she moved to the University of Málaga
in 2004, where she holds a Full Professor position at the Department of
Molecular Biology and Biochemistry. For the last 25 years, she has been devoted
to the search for and characterization of new drug candidates, with a special
focus on the inhibitors of angiogenesis. During this time, she has become an
expert in this field, as shown by her contributions in terms of scientific
papers, patent applications, books (she has been the editor of two books
published in Spanish about angiogenesis and cancer, ISBN 84-9747-035-4 and ISBN
978-84-691-5241-6), and book chapters. Her work, carried out in collaboration
with pharma companies and national/international research groups, has received
several awards. She is scientifically responsible for the Cell Culture
Laboratory of the Servicios Centrales de Apoyo a la Investigación de la
Universidad de Málaga, has been the Lead of the Department of Molecular Biology and
Biochemistry (University of Malaga), and is a promoter of the spinoff company
Drug Discovery Biotech, S.L.
Ana R. Quesada graduated in chemistry from the University of
Granada (Spain) and obtained her Ph.D. in biochemistry at the University of
Málaga (Spain). She has been a visiting scientist at the University of Bristol
(UK) and at the UWM (Wisconsin, USA). After working for seven years in the research
departments of pharmaceutical companies, she moved to the University of Málaga
in 2004, where she holds a Full Professor position at the Department of
Molecular Biology and Biochemistry. For the last 25 years, she has been devoted
to the search for and characterization of new drug candidates, with a special
focus on the inhibitors of angiogenesis. During this time, she has become an
expert in this field, as shown by her contributions in terms of scientific
papers, patent applications, books (she has been the editor of two books
published in Spanish about angiogenesis and cancer, ISBN 84-9747-035-4 and ISBN
978-84-691-5241-6), and book chapters. Her work, carried out in collaboration
with pharma companies and national/international research groups, has received
several awards. She is scientifically responsible for the Cell Culture
Laboratory of the Servicios Centrales de Apoyo a la Investigación de la
Universidad de Málaga, has been the Lead of the Department of Molecular Biology and
Biochemistry (University of Malaga), and is a promoter of the spinoff company
Drug Discovery Biotech, S.L.